Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM Induced Inflammasome Activation and Corticosteroid Resistance
NCT03307278Withdrawn
- Sponsor
- China Medical University Hospital
- Start
- Nov 2017
- Primary completion
- Sep 2018
01
Overview
Trial (2 arms), sponsored by China Medical University Hospital. Primary endpoints: Inflammasome activation by HDM at 6 hours and Steroid receptor phosphorylation by HDM at 6 hours. Planned start Nov 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT03307278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307278.